Biotechnology News

KUALA LUMPUR, Malaysia, Feb. 28, 2026 (GLOBE NEWSWIRE) -- CUKTECH, sebuah syarikat inovatif terkemuka dalam penyelesaian pengecasan pintar, hari ini mengumumkan pelancaran rasmi Bank Kuasa CUKTECH...

KUALA LUMPUR, Malaysia, Feb. 28, 2026 (GLOBE NEWSWIRE) -- CUKTECH, a leading innovator in intelligent charging solutions, today announced the official launch of its highly anticipated CUKTECH 25SE...

CLARKSBURG, Md., Feb. 27, 2026 (GLOBE NEWSWIRE) -- OpGen, Inc. (OTC: OPGN) today announced that it is changing its name to CapForce Inc., effective today. OpGen changed its name to CapForce Inc. in...

Arcutis today announced that management will participate in the TD Cowen 46th Annual Health Care Conference, taking place March 2-4, 2026, in Boston.

Company Announcement COPENHAGEN, Denmark; February 27, 2026 – Genmab A/S (Nasdaq: GMAB) - In accordance with Article 19 of Regulation No. 596/2014 on Market Abuse and Implementing Regulation...

Company Announcement COPENHAGEN, Denmark; February 27, 2026 – Genmab A/S (Nasdaq: GMAB) announced today that the Board of Directors decided to grant 587,495 restricted stock units to members of...

WARREN, N.J., Feb. 27, 2026 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN) today announced that it has entered into a signed, non-exclusive, non-binding Letter...

Opus Genetics Announces Initial Clinical Data from Phase 1/2 OPGx-BEST1 Gene Therapy Study at the Macula Society Annual Meeting

After Reevaluating its Near-term Capital Needs Given the Recent Changes in its Projected 2026 Revenue and Mayo Collaboration, the Company Determined that a $15 Million Offering is Not Required to...

RADNOR, Pa., Feb. 27, 2026 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that Company management will participate in the...